4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

86 filings reported holding FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24,702,968 shares of 46,691,176 outstanding shares and own 52.91% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (3,937,914 shares), BlackRock Inc. (2,087,682 shares), BVF INC/IL (2,005,862 shares), Deep Track Capital, LP (1,900,000 shares), JANUS HENDERSON GROUP PLC (1,647,923 shares), Octagon Capital Advisors LP (1,551,070 shares), Aquilo Capital Management, LLC (1,509,944 shares), VANGUARD GROUP INC (1,283,083 shares), STATE STREET CORP (1,259,660 shares), and FMR LLC (1,140,140 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.